Latest news with #SSIMantra


Hans India
4 days ago
- Business
- Hans India
Indian medtech startup rings bell in NY, celebrates Nasdaq debut
Hyderabad: In a defining leap for Indian medical technology on the global stage, SS Innovations International, the creators of the indigenous SSI Mantra surgical robotic system — rang the opening bell on Wednesday at the Nasdaq Market Site in New York City. The company's shares are listed under the ticker symbol 'SSII'. The ceremony was led by Dr Sudhir Srivastava, Founder, Chairman, and CEO of SS Innovations International, joined by members of the company's management team, Board of Directors, key advisors, and special guests. This milestone marks a proud moment for India, underscoring the nation's growing leadership in advanced medical technologies and heralding a new era of innovation and international recognition for Indian-origin healthcare solutions. SS Innovations International has made remarkable progress with its clinically validated and patented SSI Mantra Surgical Robotic System, which has been installed in 80 hospitals across 75 locations in India. The company has also expanded its presence internationally to countries including Nepal, Ecuador, Guatemala, the Philippines, Indonesia, Sri Lanka, Colombia and Ukraine. With over 4,000 successful robotic surgeries completed across more than 100 surgical procedures, the SSI Mantra is transforming access to advanced robotic surgery by offering a cost-effective solution to a broader patient population.


India Today
30-04-2025
- Health
- India Today
Elon Musk predicts robots will outsmart human surgeons in 5 years: Is it true?
Elon Musk has sparked a debate online saying that robots could become better than even the world's best surgeons in the next five Tesla and SpaceX CEO made this prediction while replying to a post on X by influencer Mario post highlighted the progress of robotic surgery, including the American-Irish medical device company Medtronic's Hugo robot, which recently showed a high success rate in surgeries for prostate, kidney, and bladder The Hugo robot mentioned in Nawfal's post was tested in 137 real-life surgeries and had a 98.5% success rate, well above the expected 85%, according to a pointed to his company, Neuralink, which uses a robot to perform extremely precise brain surgeries, procedures he said are too complex and delicate for human hands alone."Robots will surpass good human surgeons within a few years and the best human surgeons within [approximately] 5 year," Musk wrote. He said Neuralink's robot had to be used because the work was too fast and precise for a human IT REALLY HAPPEN IN FIVE YEARS?advertisementRobotic surgery is a type of surgery where doctors use special machines with robotic arms to help perform operations. The doctor, while sitting behind a console, controls the robot using a helps make very small, careful movements, which can lead to less pain, smaller cuts, and faster healing for the patient. A doctor carrying out a robotic surgery. () Dr Sankar Adusumilli, a US-based senior surgeon who has done over 2,400 robot-assisted surgeries, replied on Musk's post calling his prediction "misleading."He explained that robotic systems are still tools, not independent doctors."The robot doesn't do the surgery on its own. The surgeon is in control, using a console to guide the robot. Every move the robot makes comes from the surgeon. I cannot let Robot to make intricate decisions- since Every patient is different,' he added that since no two patients are the same, it takes a human to make the right decision during complex surgeries."Even the best autopilot needs a skilled human pilot - same applies to surgery," Dr Adusumilli wrote. According to Dr Sudhir Srivastava, founder of India's first indigenous surgical robot, SSI Mantra, while Musk's statement sparks an important conversation, the prediction requires said that even though robotic systems are becoming indispensable tools in surgery, the statement, however, overlooks a fundamental truth that surgery is not solely about precision."It is equally about real-time decision-making, adaptability, and patient-specific judgment," Dr. Srivastava told India Today Digital."At present, and for the foreseeable future, robots remain tools that enhance the capabilities of skilled surgeons. They do not make clinical decisions or adapt to the wide anatomical and physiological variations present in every patient. Having personally performed and overseen thousands of robotic surgeries, I can attest that a surgeon's intuition, expertise, and adaptability are irreplaceable," he said. First Indian surgical robot. (Photo: SSI Mantra) advertisementAnother US-based doctor, who goes by the name 'mckalip' according to their bio, stated that robots cannot perform surgeries alone without human help."This is false. As a neurosurgeon, I promise you that no 'robot' surgeon can ever autonomously perform brain and spine surgery or likely any surgeries effectively, appropriately or safely. Too many variables require critical thinking," the user said. An orthopaedic surgeon Dr Steven Denyer, in the comments section, said that while robots are the future, older technology will still exist. "Robots are here to stay. But we still use fax machines and whiteboards, and we can't see X-rays done at another hospital in the same city in real time," Denyer wrote. Dr Francisco Cardoso from Brazil added that the Tesla CEO's prediction holds true but only in part, stating that unexpected things happen during surgery and robots won't be able to make spontaneous surgeon needs to use creativity to solve problems, and that is what separates the best from the average. A robot is still far from having this mastery of something that it was not programmed to do," Cardoso wrote. A Musk supporter chimed in and said, "Think of the lives that could be saved with mass-produced, high-quality robotic surgeons. It could reduce healthcare costs and help in places where doctors are few."Adding to this, Dr Srivastava agreed that while surgeons do bring sound judgement, robot-assisted surgeries can transform rural healthcare, especially telesurgery, where doctors cannot reach remote technology keeps advancing, robotic surgery is becoming more common in hospitals. But experts say we're still far from a future where robots work on their own - without the help of skilled human hands.
&w=3840&q=100)

Business Standard
25-04-2025
- Business
- Business Standard
SS Innovations lists on Nasdaq; shares trade under 'SSII' ticker
SS Innovations International, the India-based manufacturer of indigenous surgical robotic systems, announced that it has listed on the United States (US) Nasdaq. The trading commences on April 25, with the company's shares listed under the ticker symbol 'SSII'. The manufacturer of robotic assistance systems (RAS) expects the move will help in expanding its operations in the US, with SSII's robotic systems currently undergoing US Food and Drug Administration (USFDA) inspection. Sudhir Srivastava, chairman of the board and chief executive officer of SS Innovations, said that the timing of SSII's uplisting coincides with its global expansion beyond India into multiple countries worldwide. 'We are pursuing the European Union (EU)'s CE Mark and USFDA approval for our SSI Mantra surgical robotic system, which we expect to receive in late 2025 and early 2026, respectively,' he said. Srivastava added that the uplisting to Nasdaq will enhance market awareness of its story, improve transparency, expand their potential investor base, and ultimately increase share liquidity. The company stated that it has reported a 3.5-fold year-on-year increase in its revenue for the year ending December 31, 2024, at $20.6 million, compared to $5.9 million reported in the previous corresponding period. 'Gross margins also showed significant improvement, rising to 40.9 per cent from 12.3 per cent in 2023, highlighting the company's robust financial performance and expanding market presence,' the company said. Srivastava added the company is looking at an advantage in the US market through its affordability factor. 'In the US, the latest robotic system sells between $2.5 million to $3 million. Even with us exporting systems from India to the US, it will cost somewhere around $1.2 million at the most,' he added. SSII adds that its surgical robotic systems have been installed in 80 hospitals across 75 locations in India. The company is also planning to expand its footprint to other countries including Nepal, Ecuador, Guatemala, the Philippines, Indonesia, Sri Lanka, and Ukraine. With over 3,700 procedures performed using the SSI Mantra, which includes more than 200 robotic cardiac procedures, Srivastava said that the system has zero reported device-related mortality, injuries, or complications.